<unk>  is an anthelmintic that is FDA approved for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older.   Common adverse reactions include eosinophilia, pruritus, musculoskeletal pain, headache, lymphopenia, tachycardia, rash, abdominal pain, hypotension, pyrexia, leukocytosis, influenza-like illness, neutropenia, cough, lymph node pain, dizziness, diarrhea, hyponatremia and peripheral swelling.
Moxidectin
Artemotil
Rubitecan
Tecovirimat
Quinalphos
Ivermectin 
Quarantine
Palifermin